CM-Path members Dr Jane Hair (Discovery Workstream), Dr Hayley Morris (Skills and Capacity Workstream Trainee), Dr Tomoko Iwata (Skills and Capacity Workstream) and Dr Karin Oien (CM-Path Chairperson) hosted Tom Haswell, CM-Path consumer, on the 30th March 2017.

Tom learnt about the importance of pathology in a cancer patients diagnosis and journey, he says:

I believe cancer research will benefit providing it is realised that pathology is a vital and integral part of cancer research and early input from pathologists in clinical trials is important, perhaps more so now in the era of precision and targeted medicines and next generation sequencing.

I felt that the pathologists appreciated the requirement of consumer involvement and I hope my visit underlined how we consumers understand the importance of pathology involvement in all aspects of cancer research.

I believe that NCRI can contribute to this by ensuring all appropriate clinical study groups (CSGs) and other NCRI initiatives include pathology.

ยป Read more from Tom’s summary of the day (PDF)

Tom Haswell and Dr Hayley Morris examine diagnostic slides

Dr Jane Hair, Tom Haswell, Dr Karin Oien and Dr Tomoko Iwata

Dr Jane Hair, Tom Haswell, Dr Karin Oien and Dr Hayley Morris

Tom Haswell and Dr Hayley Morris examine diagnostic slides